Search

everythinglearnresearchcommunity

for

Search:↓

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Upadacitinib may effectively treat alopecia areata without side effects.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Immune cells affect hair growth and could lead to new hair loss treatments.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Genetic insights can lead to personalized treatments for acne, androgenetic alopecia, and alopecia areata.

Certain drugs can change hair color, either lightening or darkening it.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Common dermatology drugs were considered but are controversial for COVID-19 treatment.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Hemp's compounds can be used in natural insecticides, cosmetics, and food supplements.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

A new method using human lung cells helps find drugs to block and reduce inflammation from SARS-CoV-2.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Vitiligo treatment requires a personalized mix of therapies to restore skin color and improve life quality.

Vaccination is the most effective way to reduce COVID-19 transmission.

K_ATP channel gene mutations are linked to heart diseases, but more research is needed to understand the connection and treatment potential.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Resolving malaria-related lung issues doesn't rely on Alox12 and leaves some inflammation.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

New treatments for seborrheic dermatitis show promise for difficult cases.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.